Charter Oak Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
VCM
VPM
Charter Oak Capital Management's IDXX Position: Q1 2026 in Review
Charter Oak Capital Management reduced its Idexx Laboratories (IDXX) stake by 1.4% in Q1 2026, selling an estimated $20.5K and leaving 2,331 shares worth $1.31M. The position accounts for 0.1% of the portfolio, ranked #68.
Charter Oak Capital Management first reported a position in IDXX in Q4 2020 and has held it in 22 quarters since. The position peaked at $4.1M in Q4 2021. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Charter Oak Capital Management held 2,331 shares of Idexx Laboratories worth $1.31M as of Q1 2026.
- Charter Oak Capital Management sold 32 Idexx Laboratories shares in Q1 2026, an estimated $20.5K.
- Idexx Laboratories made up 0.1% of Charter Oak Capital Management's portfolio in Q1 2026, its #68 holding.
- Charter Oak Capital Management first reported a position in Idexx Laboratories in Q4 2020 and has held it in 22 quarters since.
- Charter Oak Capital Management's Idexx Laboratories position peaked at $4.1M in Q4 2021.
- 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Charter Oak Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.